KRAS and neoplasm: Previously (13), we demonstrated that MEKis enhanced immune activation after RT and increased the number of tumor-infiltrating lymphocytes; moreover, several cytokines affecting tumor lymphatic infiltration were detected in MEKi and RT-treated KRAS-mutated cell lines.